EMC Instytut Medyczny SA

WSE:EMC Stok Raporu

Piyasa değeri: zł441.1m

EMC Instytut Medyczny Gelecekteki Büyüme

Future kriter kontrolleri 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for EMC Instytut Medyczny.

Anahtar bilgiler

n/a

Kazanç büyüme oranı

n/a

EPS büyüme oranı

Healthcare kazanç büyümesi21.5%
Gelir büyüme oranın/a
Gelecekteki özkaynak getirisin/a
Analist kapsamı

None

Son güncellemen/a

Gelecekteki son büyüme güncellemeleri

Güncelleme yok

Recent updates

A Piece Of The Puzzle Missing From EMC Instytut Medyczny SA's (WSE:EMC) 50% Share Price Climb

Jan 27
A Piece Of The Puzzle Missing From EMC Instytut Medyczny SA's (WSE:EMC) 50% Share Price Climb

The Return Trends At EMC Instytut Medyczny (WSE:EMC) Look Promising

Feb 10
The Return Trends At EMC Instytut Medyczny (WSE:EMC) Look Promising

Does EMC Instytut Medyczny (WSE:EMC) Have A Healthy Balance Sheet?

Dec 26
Does EMC Instytut Medyczny (WSE:EMC) Have A Healthy Balance Sheet?

EMC Instytut Medyczny (WSE:EMC) Is Looking To Continue Growing Its Returns On Capital

Nov 30
EMC Instytut Medyczny (WSE:EMC) Is Looking To Continue Growing Its Returns On Capital

Here's Why EMC Instytut Medyczny (WSE:EMC) Has A Meaningful Debt Burden

May 23
Here's Why EMC Instytut Medyczny (WSE:EMC) Has A Meaningful Debt Burden

EMC Instytut Medyczny (WSE:EMC) Is Looking To Continue Growing Its Returns On Capital

Apr 17
EMC Instytut Medyczny (WSE:EMC) Is Looking To Continue Growing Its Returns On Capital

Can You Imagine How Jubilant EMC Instytut Medyczny's (WSE:EMC) Shareholders Feel About Its 133% Share Price Gain?

Feb 26
Can You Imagine How Jubilant EMC Instytut Medyczny's (WSE:EMC) Shareholders Feel About Its 133% Share Price Gain?

EMC Instytut Medyczny (WSE:EMC) Seems To Use Debt Quite Sensibly

Jan 21
EMC Instytut Medyczny (WSE:EMC) Seems To Use Debt Quite Sensibly

Here’s What’s Happening With Returns At EMC Instytut Medyczny (WSE:EMC)

Dec 17
Here’s What’s Happening With Returns At EMC Instytut Medyczny (WSE:EMC)

Bu bölümde, yatırımcıların şirketin kâr elde etme kabiliyetini anlamalarına yardımcı olmak için genellikle profesyonel analistlerin fikir birliği tahminlerine dayanan gelir ve kazanç büyüme tahminlerini sunuyoruz. Ancak EMC Instytut Medyczny yeterli geçmiş veri sağlamadığından ve analist tahmini olmadığından, gelecekteki kazançları geçmiş verileri ekstrapole ederek veya analist tahminlerini kullanarak güvenilir bir şekilde hesaplanamaz.

SimplyWall St tarafından kapsanan şirketlerin %97'si geçmiş finansal verilere sahip olduğu için bu oldukça nadir bir durumdur.

Kazanç ve Gelir Büyüme Tahminleri

WSE:EMC - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (PLN Millions )
TarihGelirKazançlarSerbest Nakit AkışıFaaliyetlerden NakitAvg. Analist Sayısı
9/30/2023658122251N/A
6/30/202362891041N/A
3/31/20236003035N/A
12/31/2022575-2742N/A
9/30/20225512-825N/A
6/30/20225271-1321N/A
3/31/20225180-1021N/A
12/31/20215153-919N/A
9/30/2021510-3-103-70N/A
6/30/2021495-4-1114N/A
3/31/2021466-4129N/A
12/31/2020441-8-522N/A
9/30/2020423-996117N/A
6/30/2020416-8830N/A
3/31/2020417-11116N/A
12/31/2019410-81022N/A
9/30/2019430-13715N/A
6/30/2019408-15515N/A
3/31/2019390-17-66N/A
12/31/2018372-18-17-6N/A
9/30/2018329-3014N/A
6/30/2018321-3-58N/A
3/31/2018312-1-116N/A
12/31/20173071124N/A
9/30/2017299-22-2116N/A
6/30/2017294-22N/A20N/A
3/31/2017287-23N/A13N/A
12/31/2016277-23N/A18N/A
9/30/2016268-10N/A13N/A
6/30/2016262-8N/A13N/A
3/31/2016260-6N/A15N/A
12/31/2015258-4N/A14N/A
9/30/2015254-5N/A9N/A
6/30/2015251-7N/A5N/A
3/31/2015250-6N/A11N/A
12/31/2014243-5N/A8N/A
9/30/2014230-4N/A1N/A
6/30/20142140N/A14N/A
3/31/20141900N/A13N/A
12/31/20131731N/A10N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: Insufficient data to determine if EMC's forecast earnings growth is above the savings rate (3.9%).

Kazançlar ve Piyasa: Insufficient data to determine if EMC's earnings are forecast to grow faster than the Polish market

Yüksek Büyüme Kazançları: Insufficient data to determine if EMC's earnings are expected to grow significantly over the next 3 years.

Gelir ve Pazar: Insufficient data to determine if EMC's revenue is forecast to grow faster than the Polish market.

Yüksek Büyüme Geliri: Insufficient data to determine if EMC's revenue is forecast to grow faster than 20% per year.


Hisse Başına Kazanç Büyüme Tahminleri


Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: Insufficient data to determine if EMC's Return on Equity is forecast to be high in 3 years time


Büyüyen şirketleri keşfedin